Bone cancer metastases are the third most common site of cancer spread after lungs and liver.
This condition often causes severe pain that impairs patients' physical, psychological, and social well-being.
We aimed to explore the potential therapeutic benefits of magnesium hydride (MgH2) on bone cancer pain (BCP).
